Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (TBPH)
CUSIP: G8807B106
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
- Total 13F shares
- 50,097,801
- Total 13F value
- $813,117,746
- Share change
- +533,811
- Put/Call ratio
- 1192%
- SEC-reported price per share
- $16.23
- Number of holders
- 171
- Value change
- +$3,344,085
- Number of buys
- 95
- Number of sells
- 77
- Shares outstanding
- 52,046,621
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
171
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Weiss Asset Management LP
Disclosed value leader
Madison Avenue Partners, LP
Comparable rows
15/15
Latest evidence
23 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 14%
13D/G row: Weiss Asset Management LP
Showing 1-6 of 15 holder rows.
Quick read
Weiss Asset Management LP leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Weiss Asset Management LP's linked filing trail.
Comparable ownership
Top 5
Weiss Asset Management LP
14%
BlackRock, Inc.
6.5%
Madison Avenue Partners, LP
18%
Newtyn Management, LLC
8.3%
Irenic Capital Management LP
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Weiss Asset Management LP |
13D/G
3/4/5
13F
10%+ Owner · Company
|
14%
|
$149,066,629
7,457,060 shares
|
$0 | 23 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$75,785,323
4,050,525 shares
|
— | 31 Dec 2025 |
| Madison Avenue Partners, LP |
13F
Company
|
18%
|
$177,953,617
9,511,150 shares
|
— | 31 Dec 2025 |
| Newtyn Management, LLC |
13F
Company
|
8.3%
|
$80,453,000
4,300,000 shares
|
— | 31 Dec 2025 |
| Irenic Capital Management LP |
13F
Company
|
5.3%
|
$51,657,337
2,760,948 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.5%
|
$44,293,175
2,367,353 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
171
Shares
50,097,801
Rows available
171
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
171
Q1 2026 holders
171
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|